Change in muscle strength explains accelerated decline of physical function in older women with high interleukin-6 serum levels

Journal of the American Geriatrics Society

Volumn 50, Issue 12, 2002, Pages 1947-1954

  Ferrucci, Luigi ^a,b,f   Penninx, Brenda W J H ^c   Volpato, Stefano ^b   Harris, Tamara B ^b   Bandeen Roche, Karen ^d   Balfour, Jennifer ^b   Leveille, Suzanne G ^b   Fried, Linda P ^e   Guralnik, Jack M ^b  

^a INRCA   (Italy)

^b National Institute of Aging   (United States)

^c WAKE FOREST SCHOOL OF MEDICINE   (United States)

^d JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^e DEPARTMENT OF PATHOLOGY   (United States)

^f NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

Aging; Cytokines; Disability; IL 6; Inflammation; Older women

Indexed keywords

CYTOKINE; INTERLEUKIN 6;

ADULT; AGED; ARTICLE; DAILY LIFE ACTIVITY; DISABILITY; FEMALE; FITNESS; HUMAN; INFLAMMATION; KNEE; MAJOR CLINICAL STUDY; MUSCLE ATROPHY; MUSCLE STRENGTH; SELF REPORT; WALKING;

ACTIVITIES OF DAILY LIVING; AGE FACTORS; AGED; BODY MASS INDEX; COHORT STUDIES; DISABLED PERSONS; FEMALE; HUMANS; INTERLEUKIN-6; KNEE JOINT; MUSCLES; SMOKING; WALKING;

EID: 0036903170     PISSN: 00028614     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1532-5415.2002.50605.x     Document Type: Article

References (19)

1. Ferrucci L, Harris TB, Guralnik JM et al. Serum IL-6 level and the development of disability in older persons. J Am Getiatr Soc 1999;47:639-646.
2. Cannon G, St. Pierre A. Involvement of inflammatory cells and cytokines in failure to thrive. Age Nutrition 1996;7:78-81.
3. Harris T. Symposium. Sarcopenia. Diagnosis and mechanisms. Muscle mass and strength: Relation to function in population studies. J Nutr 1997;127: S1004-S1006.
4. Tisdale MJ. New cachexic factors. Curr Opin Clin Nutr Metab Care 1998;1: 253-256.
5. Cannon JG. Cytokines in aging and muscle homeostasis. J Getontol A Biol Sci Med Sci 1995;50 Spec No:120-123. Review.
6. Cannon JG. Intrinsic and extrinsic factors in muscle aging. Ann N Y Acad Sci 1998;854:72-77.
7. Fielding RA, Meredith CN, O'Reilly KI et al. Enhanced protein breakdown after eccentric exercise in young and older men. J Appl Physiol 1991;71:674-679.
8. Kasper JD, Shapito S, Guralnik JM et al. Designing a community study of moderate[y to severely disabled older women. The Women's Health Aging Study. Ann Epidemiol 1999;9:498-507.
9. Folstein MF, Folstein S, McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12:189-198.
10. Rao KMK, Pieper CS, Currie MS et al. Variability of plasma IL-6 and crosslinked fibrin dimers over time in community dwelling elderly subjects. Am J Pathol 1994;102:802-805.
11. Bandinelli S, Benvenuti E, Del Lungo I et al. Measuring muscular strength of the lower limbs by hand-held dynamometer: A standard protocol. Aging Clin Exp Res 1999;11:287-293.
12. Brink TL, Yesavage JA, Lum O et al. Screening test for geriatric depression. Clin Gerontol 1982;1:37-44.
13. Guralnik JM, Fried LP, Simonsick EM et al, eds. The Women's Health and Aging Study: Health and Social Characteristics of Older Women with Disability (NIH Publication no. 95-4009). Bethesda, MD: National Institute on Aging, 1995. (Available at http://www.nih.gov/nia/healtli/pubs/whasbook/tablcont.htm Accessed August 14, 2002).
14. Roubenoff R, Hughes VA. Sarcopenia: Current concepts. J Gerontol A Biol Sci Med Sci 2000;55A:M716-M724.
15. Henderson JT, Mullen BJ, Roder JC. Physiological effects of CNTF-induced wasting. Cytokine 1996;8:784-793.
16. Mitch WE, Goldberg AL. Mechanism of muscle wasting. N Engl J Med 1996;335:1897-1904.
17. Hager K, Machein U, Krieger S et al. Interlukin-6 and selected plasma proteins in healthy persons of different ages. Neurobiol Aging 1994;15:771-772.
18. Roubenoff R, Harris TB, Abad LW et al. Monocyte cytokine production in an elderly population. Effect of age and inflammation. J Gerontol A Biol Sci Med Sci 1998;53A:M20-M26.
19. Bruunsgaard H, Skinhoj P, Qvist J et al. Elderly humans show prolonged in vivo inflammatory activity during pneumococcal infections. J Infect Dis 1999;180:551-554.